International Flavors & Fragrances Inc

Ingredion Incorporated's Texture & Healthful Solutions segment extended its growth streak, with net sales rising 5% year over year to $627 million and net sales volumes up 7% in the second quarter of 2026, marking the ninth consecutive quarter of volume growth. Segment operating income increased 5% to $117 million, the second-highest quarterly operating income in T&HS history, while operating margin improved to 18.7% from 18.5% a year ago. The company said the volume strength was not driven by customer restocking or demand pulled forward ahead of pricing actions, and that solutions continued to grow faster than the rest of the business. For 2026, Ingredion expects T&HS net sales to rise in the mid-single digits and operating income to increase in the mid-to-high single digits, though higher tapioca costs and an unfavorable price mix could limit margin improvement. Separately, International Flavors & Fragrances reported Taste sales growth of 4% to $688 million and Health & Biosciences growth of 5% to $601 million in the second quarter of 2026, with EBITDA up 6% in both segments, while Archer-Daniels-Midland reported Nutrition operating profit of $172 million, up 51%, and Human Nutrition operating profit up 51% to $139 million.

IFF introduced AQUASCENT, a new vegan, water-based carrier for fine fragrance, on September 30, 2026. The technology, part of IFF's Science of Performance platform, is crafted from a proprietary formula made with biodegradable materials and supports fragrance loads from 10% to up to 25%, compared with up to 15% for most comparable systems. Formulated without intentionally added ethanol, preservatives or silicone, AQUASCENT maintains visual clarity while delivering enhanced olfactive performance, and can be supplied as a concentrate alone so brands add water during final production, reducing shipped volume and weight to help lower CO2 emissions from shipping. Sabrya Meflah, president of Fine Fragrance for IFF Scent, said the technology reflects continued investment in new scent technologies and formats supporting the industry's growing focus on sustainability. IFF web-listening data shows worldwide Google searches for "water-based perfumes" rose 18% year-to-date, while related TikTok content has generated more than 15 million views.

International Flavors & Fragrances has launched Omni-Bos PHY, a phytase enzyme for dairy cattle aimed at improving feed efficiency, nutrient utilization and producer profitability across key emerging regions. The animal nutrition product arrives as IFF shares trade at US$84.91, with a 30-day share price return of 4.83% and a 24.81% year-to-date gain, while total shareholder return stands at 37.06% over the past year and 32.41% over three years, against a 27.02% decline over five years. On the most followed narrative, IFF screens as 10% undervalued, with an estimated fair value of about $94.82 against the recent $84.91 share price, a case that leans on recent divestitures of commodity businesses including Pharma Solutions, Soy Crush, Concentrates and Lecithin, plus the ongoing strategic evaluation of the Food Ingredients segment. Management expects investments in R&D and capacity, especially in Health & Biosciences, Taste and Specialty Fragrance Ingredients, to accelerate revenue and profit growth beginning in 2026 and reaching full impact by 2027. A separate lens using the SWS DCF model points to a future cash flow value of $106.45 at today's $84.91 price, also flagging the stock as undervalued, though ongoing weakness in key markets and pressure in fragrance ingredients could derail the case.

International Flavors & Fragrances reported second-quarter continuing-operations sales rose 6% to nearly $2 billion and adjusted operating EBITDA increased 6% to $408 million, driven by volume growth across all segments. The company is selling its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, retaining a 10% stake, and plans to use more than $1 billion of proceeds to reduce debt while addressing about $100 million in stranded costs. IFF introduced full-year 2026 guidance for continuing operations, projecting sales of $7.4 billion to $7.6 billion and EBITDA of $1.53 billion to $1.6 billion. The board authorized a $2.5 billion share-repurchase program, with about $500 million expected to be repurchased in the second half of 2026. The company also announced an agreement to sell a portfolio of non-strategic products with about $170 million in annual sales for approximately $75 million, expected to close in the fourth quarter of 2026.

IFF announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock. The dividend is payable on October 9, 2026 to shareholders of record as of September 18, 2026.

International Flavors & Fragrances has agreed to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities to SuanNutra, a Carbyne Equity Partners portfolio company, for an undisclosed sum. The portfolio serves food, beverage, and nutritional end markets and generated approximately $170 million in revenues in 2025. The transaction includes five manufacturing facilities in Europe, the U.S., and Latin America. CEO Erik Fyrwald said the sale is another step in optimizing the portfolio and reinforces the company's focus on its core innovation-led businesses of Taste, Scent, and Health & Biosciences.

Heartland Mid Cap Value Fund highlighted International Flavors & Fragrances as a new deep-value holding in its second-quarter 2026 investor letter. The fund noted that IFF trades at 12.23 times forward EBITDA, a steep discount to industry leader Givaudan at 19.14 times, following more than two years of portfolio streamlining toward higher-margin businesses. IFF’s profits are now split across Taste at 30%, Health & Biosciences at 37%, and Scent at 32%, with encapsulated fragrance technology driving leadership in fabric care and expansion into scent boosters, shampoos, and body washes. Management recently instituted the company’s first share buyback program in six years, signaling confidence in closing the valuation gap. The fund returned 9.90% in the quarter versus the Russell Midcap Value Index’s 13.40%, with underperformance driven by negative stock selection.

The global encapsulated essential oils for feed market is projected to grow from an estimated $1.18 billion in 2026 to $1.67 billion by 2030, at a compound annual growth rate of 9.1%, according to a new report from ResearchAndMarkets.com. The report covers 16 countries and eight regions, analyzing product types including microencapsulated, nanoencapsulated, and macroencapsulated forms, with detailed subsegment breakdowns such as spray-dried microcapsules, nanoemulsions, and extruded capsules. Key companies profiled include Cargill Incorporated, Archer-Daniels-Midland Company, DSM-Firmenich AG, International Flavors & Fragrances Inc., and Symrise AG. The study highlights drivers such as the shift toward antibiotic-free livestock production, adoption of natural feed additives for gut health, and demand for controlled-release encapsulation technologies. Expanded geographic coverage includes Taiwan and Southeast Asia, reflecting ongoing manufacturing shifts and supply chain realignments.

Morgan Stanley and Argus have raised their price targets on International Flavors & Fragrances. On July 1, 2026, Morgan Stanley lifted its target to $95 from $93, maintaining an Overweight rating, citing adjusted estimates and higher peer multiples. A day earlier, Argus increased its target to $85 from $80 with a Buy rating, noting the shares are trading near the low end of their historical valuation range and that volume growth and productivity gains can drive sustained earnings growth. Also on June 30, IFF launched SENSORA, an advanced patent-pending pro-fragrance technology for home, fabric, and personal care applications, designed to deliver a longer-lasting and more sophisticated scent experience.

International Flavors & Fragrances reported first-quarter revenues of $2.74 billion, down 3.6% year on year but exceeding analysts' expectations by 3.9%, with strong beats on EBITDA and organic revenue estimates. Among the five ingredients, flavors and fragrances stocks tracked, the group's revenues were in line with consensus, though share prices have fallen 3.3% on average since reporting. Bunge Global posted the fastest revenue growth at $21.86 billion, up 87.8% year on year, but missed revenue estimates by 3.1% and its stock fell 15.7%. Ingredion's revenues of $1.79 billion, down 1.2%, were in line with expectations, but it significantly missed EBITDA and gross margin estimates, sending shares down 8.7%. Archer-Daniels-Midland reported $20.49 billion in revenues, up 1.6%, missing estimates by 1.2% with misses on gross margin and EBITDA, leaving its stock flat. Darling Ingredients' revenues rose 12.3% to $1.55 billion, in line with expectations, but a significant miss on adjusted operating income pushed shares down 10%.

International Flavors & Fragrances has launched SENSORA, a patent-pending pro-fragrance technology designed to extend scent for up to 20 days post-activation across home, fabric, and personal care applications. The first product under this portfolio is Floral Fusion, a light-activated pro-fragrance for liquid detergents that releases floral notes on dry fabrics. In its first-quarter 2026 results, IFF reported adjusted earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.08, while net sales of $2.741 billion exceeded the $2.65 billion consensus despite a 3.6% year-over-year decline. The Scent segment saw sales rise 6% to $651 million, with adjusted operating EBITDA up 5% to $148 million.